News

The agreement resolves litigation that was pending in the US District Court of Texas with respect to certain Medtronic products.

The company has streamlined its operations through a series of initiatives designed to reduce annual expenses by approximately $3.5 million to a current operating burn rate of approximately

The consideration comprises of $3 million paid in cash to PHC at closing and additional payments totaling $2 million that are contingent upon Pivotal Research Group achieving certain

According to Cordis, Nevo is the first and only drug-eluting stent utilizing a unique reservoir technology, which Cordis acquired from Conor Medsystems in 2007, and incorporates hundreds of

As the company’s chief science officer/chief medical officer, Mr Chew will establish a unified medical voice for Sanofi-Aventis US among internal and external stakeholders. Mr Chew will be

A randomized, double-blind, placebo-controlled, three-way cross-over study was conducted in 108 seasonal allergic rhinitis (SAR) patients to compare the relative efficacy of Captisol-Enabled budesonide + azelastine nasal spray

Bovie Medical, a manufacturer and marketer of electrosurgical products, has reported a net income of $38,767, or nil per diluted share, for the fourth quarter of 2008, compared

The resulting average blood levels exceeded those that have been shown in third party studies using injectable parathyroid hormone (PTH) to stimulate bone growth in osteoporotic women. No

CytRx, a clinical-stage biopharmaceutical company, has reported a net loss of $27.05m, or $0.30 per share, for the year ended December 31, 2008, compared to a net loss